Oncogenic Roles of the PI3K/AKT/mTOR axis

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · see citing works

mTOR Signaling in Growth Control and Disease

Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · see citing works

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · see citing works

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · see citing works

AKT/PKB signaling: navigating downstream

Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · see citing works

The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,041 · see citing works

Cancer drug resistance: an evolving paradigm

Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681 · see citing works

The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation

DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · see citing works

mTOR: from growth signal integration to cancer, diabetes and ageing

Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941 · see citing works

TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival

Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914 · see citing works

AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint

Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849 · see citing works

High Frequency of Mutations of the PIK3CA Gene in Human Cancers

Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448 · see citing works

Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate

Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233 · see citing works

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083 · see citing works

Molecular mechanisms of mTOR-mediated translational control

Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558 · see citing works

ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery

Jung, C. H., Jun, C. B., Ro, S.-H., Kim, Y.-M., Otto, N. M., Cao, J., Kundu, M., & Kim, D.-H. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1249 · Cited by 2,025 · see citing works

Activation of a metabolic gene regulatory network downstream of mTOR complex 1

Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020 · see citing works

The functions and regulation of the PTEN tumour suppressor

Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926 · see citing works

PI3K and cancer: lessons, challenges and opportunities

Fruman, D. A., & Rommel, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4204 · Cited by 1,716 · see citing works

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

Furman, R. R., Sharman, J. P., Coutre, S. E., Cheson, B. D., Pagel, J. M., Hillmen, P., Barrientos, J. C., Zelenetz, A. D., Kipps, T. J., Flinn, I. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315226 · Cited by 1,711 · see citing works

The landscape of cancer genes and mutational processes in breast cancer

Stephens, P. J., Tarpey, P. S., Davies, H. R., Loo, P. V., Greenman, C., Wedge, D. C., Nik‐Zainal, S., Martin, S., Varela, I., Bignell, G. R., et al. (2012) · Nature · doi:10.1038/nature11017 · Cited by 1,686 · see citing works

ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy

Ganley, I. G., Lam, D., Wang, J., Ding, X., Chen, S., & Jiang, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900573200 · Cited by 1,559 · see citing works

Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway

Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555 · see citing works

Pten is essential for embryonic development and tumour suppression

Cristofano, A. D., Pesce, B., Cordon‐Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,518 · see citing works

mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex

Cunningham, J. T., Rodgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V. K., & Puigserver, P. (2007) · Nature · doi:10.1038/nature06322 · Cited by 1,488 · see citing works

SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth

Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y.-L., & Schulze, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.007 · Cited by 1,413 · see citing works

MYC, Metabolism, and Cancer

Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375 · see citing works

PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting

Thorpe, L. M., Yuzugullu, H., & Zhao, J. J. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3860 · Cited by 1,365 · see citing works

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

Engelman, J. A., Chen, L., Tan, X., Crosby, K., Guimaraes, A. R., Upadhyay, R., Maira, M., McNamara, K., Perera, S. A., Song, Y., et al. (2008) · Nature Medicine · doi:10.1038/nm.1890 · Cited by 1,330 · see citing works

The translational landscape of mTOR signalling steers cancer initiation and metastasis

Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313 · see citing works

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

Carpten, J. D., Faber, A. L., Horn, C. L., Donoho, G. P., Briggs, S., Robbins, C. M., Hostetter, G. H., Boguslawski, S. J., Moses, T. Y., Savage, S., et al. (2007) · Nature · doi:10.1038/nature05933 · Cited by 1,291 · see citing works

Phosphoinositide kinases.

Fruman, D. A., Meyers, R., & Cantley, L. C. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.481 · Cited by 1,261 · see citing works

The TSC1–TSC2 complex: a molecular switchboard controlling cell growth

Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237 · cited 2× · see citing works

PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236 · see citing works

mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway

Peterson, T. R., Sengupta, S., Harris, T. E., Carmack, A. E., Kang, S. A. W., Balderas, E., Guertin, D. A., Madden, K. L., Carpenter, A. E., Finck, B. N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.034 · Cited by 1,233 · see citing works

Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin

Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., & Abraham, R. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7004-7014.2002 · Cited by 1,186 · see citing works

Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40

Haar, E. V., Lee, S.-I., Bandhakavi, S., Griffin, T. J., & Kim, D. (2007) · Nature Cell Biology · doi:10.1038/ncb1547 · Cited by 1,185 · see citing works

Sequence analysis of mutations and translocations across breast cancer subtypes

Banerji, S. O., Cibulskis, K., Rangel‐Escareño, C., Brown, K., Carter, S. L., Frederick, A. M., Lawrence, M. S., Sivachenko, A., Sougnez, C. L., Zou, L., et al. (2012) · Nature · doi:10.1038/nature11154 · Cited by 1,181 · see citing works

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

Gopal, A. K., Kahl, B. S., de Vos, S., Wagner‐Johnston, N. D., Schuster, S. J., Jurczak, W. J., Flinn, I. W., Flowers, C. R., Martin, P., Viardot, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314583 · Cited by 1,069 · see citing works

The LKB1 tumor suppressor negatively regulates mTOR signaling

Shaw, R. J., Bardeesy, N. M., Manning, B. D., Lopez, L. V., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,067 · see citing works

An integrative genomic and proteomic analysis of pik3ca, pten, and akt mutations in breast cancer.

Stemke-Hale, K., Gonzalez-Angulo, A. M., Lluch, A., Neve, R. M., Kuo, W.-L., Davies, M., Carey, M., Hu, Z., Guan, Y., Sahin, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6854 · Cited by 1,054 · see citing works

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR

Neshat, M., Mellinghoff, I., Tran, C., Stiles, B. L., Thomas, G., Petersen, R., Frost, P., Gibbons, J., Wu, H., & Sawyers, C. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.171076798 · Cited by 1,033 · see citing works

Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate

Whitman, M., Downes, C. P., Keeler, M. L., Keller, T. L., & Cantley, L. C. (1988) · Nature · doi:10.1038/332644a0 · Cited by 1,018 · see citing works

Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap

Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 965 · see citing works

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964 · see citing works

Akt regulates growth by directly phosphorylating Tsc2

Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959 · see citing works

Phosphoinositide 3-kinases: A conserved family of signal transducers

Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., & Waterfield, M. D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01061-x · Cited by 958 · see citing works

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

Wendel, H., de Stanchina, E., Fridman, J. S., Malina, A., Ray, S., Kogan, S. C., Cordon‐Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 956 · see citing works

Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems

Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon‐Cardo, C., Cattoretti, G., Fisher, P. E., & Parsons, R. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1563 · Cited by 947 · see citing works

A Retroviral Oncogene, akt , Encoding a Serine-Threonine Kinase Containing an SH2-Like Region

Bellacosa, A., Testa, J. R., Staal, S. P., & Tsichlis, P. N. (1991) · Science · doi:10.1126/science.1833819 · Cited by 939 · see citing works

PHLPP: A phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth

Gao, T., Furnari, F., & Newton, A. C. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.008 · Cited by 906 · see citing works

mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation

Morita, M., Gravel, S.-P., Chénard, V., Sikström, K., Zheng, L., Alain, T., Gandin, V., Avizonis, D., Arguello, M., Zakaria, C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.001 · Cited by 842 · see citing works

Novel mutations target distinct subgroups of medulloblastoma

Robinson, G. W., Parker, M. D., Kranenburg, T. A., Lu, C., Chen, X. '., Ding, L., Phoenix, T. N., Hedlund, E., Wei, L., Zhu, X., et al. (2012) · Nature · doi:10.1038/nature11213 · Cited by 835 · see citing works

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

Kang, S., Bader, A. G., & Vogt, P. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408864102 · Cited by 827 · see citing works

The PI3K/AKT Pathway as a Target for Cancer Treatment

Mayer, I. A., & Arteaga, C. L. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-062913-051343 · Cited by 826 · see citing works

Targeting the translation machinery in cancer

Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799 · see citing works

mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle

Ben-Sahra, I., Hoxhaj, G., Ricoult, S. J. H., Asara, J. M., & Manning, B. D. (2016) · Science · doi:10.1126/science.aad0489 · Cited by 795 · see citing works

PTEN loss in the continuum of common cancers, rare syndromes and mouse models

Hollander, M. C., Blumenthal, G. M., & Dennis, P. A. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3037 · Cited by 793 · see citing works

Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1

Ben-Sahra, I., Howell, J. J., Asara, J. M., & Manning, B. D. (2013) · Science · doi:10.1126/science.1228792 · Cited by 739 · see citing works

Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis

Jia, S., Liu, Z., Zhang, S., Liu, P., Zhang, L., Lee, S., Zhang, J., Signoretti, S., Loda, M. F., Roberts, T. M., et al. (2008) · Nature · doi:10.1038/nature07091 · Cited by 691 · see citing works

Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage

Angulo, I., Vadas, O., Garçon, F., Banham-Hall, E., Plagnol, V., Leahy, T. R., Baxendale, H., Coulter, T. I., Curtis, J. W., Wu, C., et al. (2013) · Science · doi:10.1126/science.1243292 · Cited by 639 · see citing works

Mutations in a signalling pathway

Parsons, D. W., Wang, T., Samuels, Y., Bardelli, A., Cummins, J. M., Wood, L. D., Silliman, N., Ptak, J., Szabo, S., Willson, J. K. V., et al. (2005) · Nature · doi:10.1038/436792a · Cited by 599 · see citing works

Class I PI3K in oncogenic cellular transformation

Zhao, L., & Vogt, P. K. (2008) · Oncogene · doi:10.1038/onc.2008.244 · Cited by 598 · see citing works

Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes

Narita, M., Young, A. R. J., Arakawa, S., Samarajiwa, S. A., Nakashima, T., Yoshida, S., Hong, S., Berry, L. S., Reichelt, S., Ferreira, M., et al. (2011) · Science · doi:10.1126/science.1205407 · Cited by 594 · see citing works

The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

Ruggero, D., Montanaro, L., Ma, L., Xu, W. G., Londei, P., Cordon‐Cardo, C., & Pandolfi, P. P. (2004) · Nature Medicine · doi:10.1038/nm1042 · Cited by 592 · see citing works

Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice

Gupta, S., Ramjaun, A. R., Haiko, P., Wang, Y., Warne, P. H., Nicke, B., Nye, E. L., Stamp, G., Alitalo, K. K., & Downward, J. (2007) · Cell · doi:10.1016/j.cell.2007.03.051 · Cited by 589 · see citing works

The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4

Csibi, A., Fendt, S.-M., Li, C., Poulogiannis, G., Choo, A. Y., Chapski, D. J., Jeong, S. M., Dempsey, J. M., Parkhitko, A., Morrison, T., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.023 · Cited by 586 · see citing works

Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway

Lamouille, S., & Derynck, R. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611146 · Cited by 573 · see citing works

An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten +/− mice

Podsypanina, K., Lee, R. T., Politis, C., Hennessy, I., Crane, A., Puc, J. A., Neshat, M. S., Wang, H., Yang, L., Gibbons, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171060098 · Cited by 570 · see citing works

The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations

Huang, C., Mandelker, D. L., Schmidt‐Kittler, O., Samuels, Y., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., Gabelli, S. B., & Amzel, L. M. (2007) · Science · doi:10.1126/science.1150799 · Cited by 564 · see citing works

mTOR coordinates protein synthesis, mitochondrial activity and proliferation

Morita, M., Gravel, S.-P., Hulea, L., Larsson, O., Pollak, M., St-Pierre, J., & Topisirovic, I. (2015) · Cell Cycle · doi:10.4161/15384101.2014.991572 · Cited by 552 · see citing works

PTEN-deficient cancers depend on PIK3CB

Wee, S., Wiederschain, D., Maira, S.-M., Loo, A. T., Miller, C., deBeaumont, R. S., Stegmeier, F. P., Yao, Y.-M., & Christoph Lengauer, C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802655105 · Cited by 545 · see citing works

mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways

Gulhati, P., Bowen, K. A., Liu, J., Stevens, P. D., Rychahou, P. G., Chen, M., Lee, E. Y., Weiss, H. L., O’Connor, K. L., Gao, T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4058 · Cited by 544 · see citing works

eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression

Furic, L., Rong, L., Larsson, O. S., Koumakpayi, I. H., Yoshida, K., Brueschke, A., Petroulakis, E., Robichaud, N., Pollak, M., Gaboury, L. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005320107 · Cited by 528 · see citing works

Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis

Robitaille, A. M., Christen, S., Shimobayashi, M., Cornu, M., Fava, L. L., Moes, S., Prescianotto-Baschong, C., Sauer, U., Jenoe, P., & Hall, M. N. (2013) · Science · doi:10.1126/science.1228771 · Cited by 525 · see citing works

Dissecting eIF4E action in tumorigenesis.Preprint

Wendel, H., Silva, R. L. A., Malina, A., Mills, J., Zhu, H., Ueda, T., Watanabe‐Fukunaga, R., Fukunaga, R., Teruya-Feldstein, J., Pelletier, J., et al. (2007) · Genes & Development · doi:10.1101/gad.1604407 · Cited by 512 · see citing works

Breast Cancer–Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells

Isakoff, S. J., Engelman, J. A., Irie, H. Y., Luo, J., Brachmann, S. M., Pearline, R. V., Cantley, L. C., & Brugge, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2612 · Cited by 505 · see citing works

Structural insights into phosphoinositide 3-kinase catalysis and signalling

Walker, E. H., Perišić, O., Ried, C., Stephens, L., & Williams, R. L. (1999) · Nature · doi:10.1038/46319 · Cited by 501 · see citing works

Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes

Simonsen, A., & Tooze, S. A. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200907014 · Cited by 500 · see citing works

High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability

Cheung, L. W. T., Hennessy, B. T., Li, J., Yu, S., Myers, A. P., Djordjevic, B., Lu, Y., Stemke‐Hale, K., Dyer, M. D., Zhang, F., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0039 · Cited by 469 · see citing works

Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors

LoRusso, P. M. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.0018 · Cited by 467 · see citing works

Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E

Hsieh, A. C., Costa, M. D., Zollo, O., Davis, C. B., Feldman, M. E., Testa, J. R., Meyuhas, O., Shokat, K. M., & Ruggero, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.021 · Cited by 464 · see citing works

Inside and out: the activities of senescence in cancer

Pérez-Mancera, P. A., Young, A. R. J., & Narita, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3773 · Cited by 462 · see citing works

Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol.

Sugimoto, Y., Whitman, M., Cantley, L. C., & Erikson, R. L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.2117 · Cited by 462 · see citing works

mTOR Signaling in Disease

Dazert, E., & Hall, M. N. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.09.003 · Cited by 460 · see citing works

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study

Coulter, T. I., Chandra, A., Bacon, C. M., Babar, J. L., Curtis, J. W., Screaton, N., Goodlad, J. R., Farmer, G., Steele, C. L., Leahy, T. R., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.021 · Cited by 457 · see citing works

Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling

Gewinner, C. A., Wang, Z. C., Richardson, A. L., Teruya‐Feldstein, J., Etemadmoghadam, D., Bowtell, D. D. L., Barretina, J., Lin, W. M., Rameh, L. E., Salmena, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.006 · Cited by 456 · see citing works

AKT1/PKBα Kinase Is Frequently Elevated in Human Cancers and Its Constitutive Activation Is Required for Oncogenic Transformation in NIH3T3 Cells

Sun, M., Wang, G., Paciga, J. E., Feldman, R. I., Yuan, Z., Xiaoling, M., Shelley, S. A., Jove, R., Tsichlis, P. N., Nicosia, S. V., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61714-2 · Cited by 454 · see citing works

eIF4E – from translation to transformation

Mamane, Y., Petroulakis, E., Rong, L., Yoshida, K., Ler, L. W., & Sonenberg, N. (2004) · Oncogene · doi:10.1038/sj.onc.1207549 · Cited by 452 · see citing works

Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanisms

Zhao, L., & Vogt, P. K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712169105 · Cited by 438 · see citing works

A diverse array of cancer-associated mTOR mutations are hyperactivating and can predict rapamycin sensitivity

Grabiner, B., Nardi, V., Birsoy, K., Possemato, R., Shen, K., Sinha, S., Jordan, A. A., Beck, A. H., & Sabatini, D. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0929 · Cited by 418 · see citing works

Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate

Posor, Y., Eichhorn‐Grünig, M., Puchkov, D., Schöneberg, J., Ullrich, A., Lampe, A., Müller, R., Zarbakhsh, S., Gulluni, F., Hirsch, E., et al. (2013) · Nature · doi:10.1038/nature12360 · Cited by 414 · see citing works

Transformation of Chicken Cells by the Gene Encoding the Catalytic Subunit of PI 3-Kinase

Chang, H. W., Aoki, M., Fruman, D. A., Auger, K. R., Bellacosa, A., Tsichlis, P. N., Cantley, L. C., Roberts, T. M., & Vogt, P. K. (1997) · Science · doi:10.1126/science.276.5320.1848 · Cited by 412 · see citing works

mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice

Guertin, D. A., Stevens, D. M., Saitoh, M., Kinkel, S., Crosby, K., Sheen, J.-H., Mullholland, D. J., Magnuson, M. A., Wu, H., & Sabatini, D. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.017 · Cited by 402 · see citing works

Phosphoinositide signalling in cancer: beyond PI3K and PTEN

Bunney, T. D., & Katan, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2842 · Cited by 400 · see citing works

mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3

Dodd, K. M., Yang, J., Shen, M. H., Sampson, J. R., & Tee, A. R. (2014) · Oncogene · doi:10.1038/onc.2014.164 · Cited by 391 · see citing works

Tsc2+/– mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background

Onda, H., Lueck, A., Marks, P. W., Warren, H. B., & Kwiatkowski, D. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7319 · Cited by 391 · see citing works

Differential Requirements for eIF4E Dose in Normal Development and Cancer

Truitt, M., Conn, C. S., Shi, Z., Pang, X., Tokuyasu, T. A., Coady, A. M., Seo, Y., Barna, M., & Ruggero, D. (2015) · Cell · doi:10.1016/j.cell.2015.05.049 · Cited by 374 · see citing works

Functional Analysis of PIK3CA Gene Mutations in Human Colorectal Cancer

Ikenoue, T., Kanai, F., Hikiba, Y., Obata, T., Tanaka, Y., Imamura, J., Ohta, M., Jazag, A., Guleng, B., Tateishi, K., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4114 · Cited by 366 · see citing works

Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer

Eser, S., Reiff, N., Messer, M., Seidler, B., Gottschalk, K., Dobler, M., Hieber, M., Arbeiter, A., Klein, S., Kong, B., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.023 · Cited by 360 · see citing works

Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning

Cai, S.-L., Tee, A. R., Short, J. D., Bergeron, J. M., Kim, J., Shen, J., Guo, R., Johnson, C. L., Kiguchi, K., & Walker, C. L. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200507119 · Cited by 359 · see citing works

High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.

Stambolic, V., Tsao, M., MacPherson, D. P., Suzuki, A., Chapman, W. B., & Mak, T. W. (2000) · PubMed · Cited by 353 · see citing works

Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity

Keymeulen, A. V., Lee, M. Y., Ousset, M., Brohée, S., Rorive, S., Giraddi, R. R., Wuidart, A., Bouvencourt, G., Dubois, C., Salmon, I. J., et al. (2015) · Nature · doi:10.1038/nature14665 · Cited by 353 · see citing works

Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells

Avdulov, S. V., Li, S., Michalek, V. N., Burrichter, D., Peterson, M., Perlman, D., Manivel, J. C., Sonenberg, N., Yee, D., Bitterman, P. B., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.024 · Cited by 341 · see citing works

PIK3CAH1047R induces multipotency and multi-lineage mammary tumours

Koren, S., Reavie, L. B., Couto, J. P., Silva, D. D., Stadler, M. B., Roloff, T. C., Britschgi, A., Eichlisberger, T., Kohler, H., Aina, O. H., et al. (2015) · Nature · doi:10.1038/nature14669 · Cited by 328 · see citing works

The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cells

Zhao, J. J., Liu, Z., Wang, L., Shin, E., Loda, M. F., & Roberts, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508988102 · Cited by 326 · see citing works

A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma

Collisson, E. A., Trejo, C. L., Silva, J. M., Gu, S., Korkola, J. E., Heiser, L. M., Charles, R., Rabinovich, B. A., Hann, B. C., Dankort, D. L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0347 · Cited by 320 · see citing works

A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt

Aoki, M., Blazek, E., & Vogt, P. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.136 · Cited by 306 · see citing works

Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis

Sander, S., Calado, D. P., Srinivasan, L., Köchert, K., Zhang, B., Rosołowski, M., Rodig, S. J., Holzmann, K., Stilgenbauer, S., Siebert, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.012 · Cited by 300 · see citing works

Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α ( <i>PIK3CA</i> )

Burke, J. E., Perisic, O., Masson, G. R., Vadas, O., & Williams, R. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205508109 · Cited by 300 · see citing works

Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model

Majumder, P., Yeh, J.-J., George, D., Febbo, P., Kum, J., Xue, Q., Bikoff, R., Ma, H.-K., Kantoff, P., Golub, T., et al. (2003) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1232229100 · Cited by 299 · see citing works

A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane

Mandelker, D. L., Gabelli, S. B., Schmidt‐Kittler, O., Zhu, J., Cheong, I., Huang, C., Kinzler, K. W., Vogelstein, B., & Amzel, L. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908444106 · Cited by 298 · see citing works

The Akt kinase: Molecular determinants of oncogenicity

Aoki, M., Batista, O., Bellacosa, A., Tsichlis, P. N., & Vogt, P. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14950 · Cited by 297 · see citing works

mTOR inhibitors in cancer therapy

Zaytseva, Y. Y., Valentino, J. D., Gulhati, P., & Evers, B. M. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.005 · Cited by 292 · see citing works

Oncogenic Mutations of PIK3CA in Human Cancers

Samuels, Y., & Waldman, T. (2010) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2010_68 · Cited by 291 · see citing works

Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation

Jaiswal, B. S., Janakiraman, V., Kljavin, N. M., Chaudhuri, S., Stern, H. M., Wang, W., Kan, Z., Dbouk, H. A., Peters, B. A., Waring, P., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.016 · Cited by 288 · see citing works

mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis

Iglesias-Bartolome, R., Patel, V., Cotrim, A., Leelahavanichkul, K., Molinolo, A. A., Mitchell, J. B., & Gutkind, J. S. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.06.007 · Cited by 284 · see citing works

Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers

Fedele, C. G., Ooms, L. M., Ho, M., Vieusseux, J. L., O'Toole, S. A., Millar, E. K. A., López‐Knowles, E., Sriratana, A., Gurung, R., Baglietto, L., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015245107 · Cited by 283 · see citing works

Activation of Akt (Protein Kinase B) in Mammary Epithelium Provides a Critical Cell Survival Signal Required for Tumor Progression

Hutchinson, J. N., Jin, J., Cardiff, R. D., Woodgett, J. R., & Muller, W. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2203-2212.2001 · Cited by 281 · see citing works

Transforming protein of avian sarcoma virus UR2 is associated with phosphatidylinositol kinase activity: possible role in tumorigenesis.

Macara, I. G., Marinetti, G. V., & Balduzzi, P. C. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.9.2728 · Cited by 279 · see citing works

Cancer-Associated PTEN Mutants Act in a Dominant-Negative Manner to Suppress PTEN Protein Function

Papa, A., Wan, L., Bonora, M., Salmena, L., Song, M. S., Hobbs, R. M., Lunardi, A., Webster, K. A., Ng, C., Newton, R. H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.03.027 · Cited by 277 · see citing works

Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice.

Kobayashi, T., Minowa, O., Kuno, J., Mitani, H., Hino, O., & Noda, T. (1999) · PubMed · Cited by 275 · see citing works

Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase

Kang, S., Denley, A., Vanhaesebroeck, B., & Vogt, P. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510772103 · Cited by 268 · see citing works

Phosphorylation of the Eukaryotic Translation Initiation Factor eIF4E Contributes to Its Transformation and mRNA Transport Activities

Topisirovic, I., Ruiz-Gutierrez, M., & Borden, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2677 · Cited by 267 · see citing works

Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms

Liu, P., Cheng, H.-L. M., Santiago, S., Raeder, M. B., Zhang, F., Isabella, A. J., Yang, J., Semaan, D. J., Chen, C., Fox, E. A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2402 · Cited by 258 · see citing works

A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice

Kobayashi, T., Minowa, O., Sugitani, Y., Takai, S., Mitani, H., Kobayashi, E., Noda, T., & Hino, O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151033798 · Cited by 251 · see citing works

Activation of Akt-1 (PKB-α) Can Accelerate ErbB-2-Mediated Mammary Tumorigenesis but Suppresses Tumor Invasion

Hutchinson, J. N., Jin, J., Cardiff, R. D., Woodgett, J. R., & Muller, W. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3465 · Cited by 251 · see citing works

The deficiency of Akt1 is sufficient to suppress tumor development in Pten +/− micePreprint

Chen, M.-L., Xu, P.-Z., Peng, X.-D., Chen, W. S., Guzman, G., Yang, X., Cristofano, A. D., Pandolfi, P. P., & Hay, N. (2006) · Genes & Development · doi:10.1101/gad.1395006 · Cited by 241 · see citing works

Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner

Skeen, J. E., Bhaskar, P. T., Chen, C.-C., Chen, W. S., Peng, X.-D., Nogueira, V., Hahn-Windgassen, A., Kiyokawa, H., & Hay, N. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.022 · Cited by 232 · see citing works

Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma

Yang, Q., Modi, P., Newcomb, T. G., Quéva, C., & Gandhi, V. V. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2034 · Cited by 226 · see citing works

Epigenetic Activation of a Subset of mRNAs by eIF4E Explains Its Effects on Cell Proliferation

Mamane, Y., Petroulakis, E., Martineau, Y., Sato, T., Larsson, O. S., Rajasekhar, V. K., & Sonenberg, N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000242 · Cited by 222 · see citing works

Signalling to eIF4E in cancer

Siddiqui, N., & Sonenberg, N. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150126 · Cited by 220 · see citing works

Translational control and metastatic progression: Enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs

Graff, J. R., & Zimmer, S. G. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022943419011 · Cited by 215 · see citing works

An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice

Kinross, K. M., Montgomery, K. G., Kleinschmidt, M., Waring, P., Ivetac, I., Tikoo, A., Saad, M., Hare, L., Roh, V., Mantamadiotis, T., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59309 · Cited by 215 · see citing works

Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer

Sato, T., Nakashima, A., Guo, L., Coffman, K., & Tamanoi, F. (2010) · Oncogene · doi:10.1038/onc.2010.28 · Cited by 214 · see citing works

Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer

Lien, E. C., Lyssiotis, C. A., & Cantley, L. C. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_3 · Cited by 211 · see citing works

Drugging PI3K in cancer: refining targets and therapeutic strategies

Yap, T. A., Bjerke, L. M., Clarke, P. A., & Workman, P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.05.016 · Cited by 204 · see citing works

PI3K Class II α Controls Spatially Restricted Endosomal PtdIns3P and Rab11 Activation to Promote Primary Cilium Function

Franco, I., Gulluni, F., Campa, C. C., Costa, C., Margaria, J. P., Ciraolo, E., Martini, M., Monteyne, D., Luca, E. D., Germena, G., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.01.022 · Cited by 199 · see citing works

Signaling specificity in the Akt pathway in biology and disease

Toker, A., & Marmiroli, S. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.04.001 · Cited by 189 · see citing works

Requirement for Interaction of PI3-Kinase p110α with RAS in Lung Tumor Maintenance

Castellano, E., Sheridan, C., Thin, M. Z., Nye, E. L., Spencer‐Dene, B., Diefenbacher, M. E., Moore, C., Kumar, M. S., Murillo, M. M., Gronroos, E. C., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.012 · Cited by 184 · see citing works

Identification of PHLPP1 as a Tumor Suppressor Reveals the Role of Feedback Activation in PTEN-Mutant Prostate Cancer Progression

Chen, M., Pratt, C. P., Zeeman, M. E., Schultz, N. D., Taylor, B. S., O’Neill, A., Castillo-Martín, M., Nowak, D. G., Naguib, A., Grace, D., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.07.013 · Cited by 174 · see citing works

Akt1 and Akt2 Play Distinct Roles in the Initiation and Metastatic Phases of Mammary Tumor Progression

Dillon, R. L., Marcotte, R., Hennessy, B. T., Woodgett, J. R., Mills, G. B., & Muller, W. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4287 · Cited by 169 · see citing works

Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation

Adams, J. R., Xu, K., Liu, J. C., Agamez, N. M. R., Loch, A. J., Wong, R. G., Wang, W., Wright, K. L., Lane, T. F., Zacksenhaus, E., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0738 · Cited by 162 · see citing works

Functional Characterization of an Isoform-Selective Inhibitor of PI3K-p110β as a Potential Anticancer Agent

Ni, J., Liu, Q., Xie, S., Carlson, C. B., Von, T., Vogel, K. W., Riddle, S., Benes, C. H., Eck, M. J., Roberts, T. M., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0003 · Cited by 162 · see citing works

Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors.

Larsson, O., Li, S.-N., Issaenko, O. A., Avdulov, S. V., Peterson, M., Smith, K. A., Bitterman, P., & Polunovsky, V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0752 · Cited by 162 · see citing works

In Vitro Budding of Intralumenal Vesicles into Late Endosomes Is Regulated by Alix and Tsg101

Falguières, T., Luyet, P., Bissig, C., Scott, C. C., Velluz, M., & Gruenberg, J. E. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-03-0239 · Cited by 155 · see citing works

Cancer-derived mutations in the regulatory subunit p85α of phosphoinositide 3-kinase function through the catalytic subunit p110α

Sun, M., Hillmann, P., Hofmann, B. T., Hart, J. R., & Vogt, P. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009652107 · Cited by 150 · see citing works

SGK3 mediates INPP4B-dependent PI 3-Kinase signaling in breast cancer

Gasser, J. A., Inuzuka, H., Lau, A., Wei, W.-Y., Beroukhim, R., & Toker, A. (2014) · Molecules and Cells · doi:10.1016/j.molcel.2014.09.023 · Cited by 147 · see citing works

The COMBREX Project: Design, Methodology, and Initial Results

Anton, B. P., Chang, Y.-C., Brown, P. C., Choi, H.-P., Faller, L. L., Guleria, J., Hu, Z., Klitgord, N., Levy‐Moonshine, A., Maksad, A., et al. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001638 · Cited by 147 · see citing works

Retroviral oncogenes: a historical primer

Vogt, P. K. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3320 · Cited by 140 · see citing works

PI3K Regulation of RAC1 Is Required for KRAS-Induced Pancreatic Tumorigenesis in Mice

Wu, C.-Y. C., Carpenter, E. S., Takeuchi, K. K., Halbrook, C. J., Peverley, L. V., Bien, H., Hall, J. C., DelGiorno, K. E., Pal, D., Song, Y., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.032 · Cited by 136 · see citing works

AKT Signaling in Physiology and Disease

Vasudevan, K. M., & Garraway, L. A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_66 · Cited by 131 · see citing works

Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases

Hon, W.-C., Berndt, A., & Williams, R. L. (2012) · Oncogene · doi:10.1038/onc.2011.532 · Cited by 129 · see citing works

Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110αPreprint

Baer, R., Cintas, C., Dufresne, M., Cassant-Sourdy, S., Schönhuber, N., Planque, L., Lulka, H., Couderc, B., Bousquet, C., Garmy-Susini, B., et al. (2014) · Genes & Development · doi:10.1101/gad.249409.114 · Cited by 129 · see citing works

The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesisPreprint

Utermark, T., Rao, T., Cheng, H.-L. M., Wang, Q., Lee, S., Wang, Z. C., Iglehart, J. D., Roberts, T. M., Muller, W. J., & Zhao, J. J. (2012) · Genes & Development · doi:10.1101/gad.191973.112 · Cited by 128 · see citing works

The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and Metastasis

Ooms, L. M., Binge, L. C., Davies, E. M., Rahman, P., Conway, J. R. W., Gurung, R., Ferguson, D. T., Papa, A., Fedele, C. G., Vieusseux, J. L., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.07.003 · Cited by 127 · see citing works

Toward rapamycin analog (rapalog)-based precision cancer therapy

Meng, L.-H., & Zheng, X. F. S. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.68 · Cited by 125 · see citing works

Luminal Expression of PIK3CA Mutant H1047R in the Mammary Gland Induces Heterogeneous Tumors

Meyer, D. S., Brinkhaus, H., Müller, U., Müller, M., Cardiff, R. D., & Bentires‐Alj, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3827 · Cited by 125 · see citing works

Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression

Turner, K. M., Sun, Y., Ji, P., Granberg, K. J., Bernard, B. M., Hu, L., Cogdell, D. E., Zhou, X., Yli-Harja, O. P., Nykter, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414573112 · Cited by 124 · see citing works

Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic eventsPreprint

Nardella, C., Chen, Z., Salmena, L., Carracedo, A., Alimonti, A., Egia, A., Carver, B. S., Gerald, W. L., Cordon‐Cardo, C., & Pandolfi, P. P. (2008) · Genes & Development · doi:10.1101/gad.1699608 · Cited by 117 · see citing works

Phosphatidylinositol 3-Kinase: The Oncoprotein

Vogt, P. K., Hart, J. R., Gymnopoulos, M., Jiang, H., Kang, S., Bader, A. G., Zhao, L., & Denley, A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_80 · Cited by 115 · see citing works

Tumorigenic activity and therapeutic inhibition of Rheb GTPasePreprint

Mavrakis, K. J., Zhu, H., Silva, R. L. A., Mills, J. R., Teruya‐Feldstein, J., Lowe, S. W., Tam, W., Pelletier, J., & Wendel, H. (2008) · Genes & Development · doi:10.1101/gad.1690808 · Cited by 113 · see citing works

Gain of Interaction with IRS1 by p110α-Helical Domain Mutants Is Crucial for Their Oncogenic Functions

Hao, Y., Wang, C., Cao, B., Hirsch, B. M., Song, J. K., Markowitz, S. D., Ewing, R. M., Sedwick, D., Liu, L., Zheng, W., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.03.021 · Cited by 109 · see citing works

Targeting LKB1 signaling in cancer

Korsse, S. E., Peppelenbosch, M. P., & van Veelen, W. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.12.006 · Cited by 107 · see citing works

Oncogenic signaling of class I PI3K isoforms

Denley, A., Kang, S. G., Kärst, U., & Vogt, P. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210918 · Cited by 105 · see citing works

Activating BRAF and PIK3CA Mutations Cooperate to Promote Anaplastic Thyroid Carcinogenesis

Charles, R., Silva, J. M., Iezza, G., Phillips, W. A., & McMahon, M. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0158-t · Cited by 104 · see citing works

Structural comparisons of class I phosphoinositide 3-kinases

Amzel, L. M., Huang, C., Mandelker, D. L., Christoph Lengauer, C., Gabelli, S. B., & Vogelstein, B. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2443 · Cited by 103 · see citing works

Oncogenic transformation induced by membrane-targeted Akt2 and Akt3

Mende, I., Malstrom, S. E., Tsichlis, P. N., Vogt, P. K., & Aoki, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204486 · Cited by 102 · see citing works

Inherited PTEN mutations and the prediction of phenotype

Leslie, N. R., & Longy, M. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.01.030 · Cited by 102 · see citing works

Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus

Malstrom, S. E., Tili, E., Kappes, D. J., Ceci, J. D., & Tsichlis, P. N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231467698 · Cited by 95 · see citing works

Deregulated Activity of Akt in Epithelial Basal Cells Induces Spontaneous Tumors and Heightened Sensitivity to Skin Carcinogenesis

Segrelles, C., Lu, J., Hammann, B. D., Santos, M., Moral, M., Cascallana, J. L., Lara, M. F., Rho, O., Carbajal, S., Traag, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2564 · Cited by 94 · see citing works

Mammalian Target of Rapamycin Activator RHEB Is Frequently Overexpressed in Human Carcinomas and Is Critical and Sufficient for Skin Epithelial Carcinogenesis

Lu, Z. H., Shvartsman, M. B., Lee, A. Y., Shao, J. M., Murray, M. M., Kladney, R. D., Fan, D., Krajewski, S., Chiang, G. G., Mills, G. B., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3467 · Cited by 92 · see citing works

An activated mTOR mutant supports growth factor-independent, nutrient-dependent cell survival

Edinger, A. L., & Thompson, C. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207738 · Cited by 91 · see citing works

Akt1 deletion prevents lung tumorigenesis by mutant K-ras

Hollander, M. C., Maier, C. R., Hobbs, E. A., Ashmore, A. R., Linnoila, R. I., & Dennis, P. A. (2011) · Oncogene · doi:10.1038/onc.2010.556 · Cited by 90 · see citing works

Multiple roles for the p85α isoform in the regulation and function of PI3K signalling and receptor trafficking

Mellor, P., Furber, L. A., Nyarko, J. N. K., & Anderson, D. H. (2011) · Biochemical Journal · doi:10.1042/bj20111164 · Cited by 90 · see citing works

MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to mTOR Inhibitors

Clegg, N. J., Couto, S. S., Wongvipat, J., Hieronymus, H., Carver, B. S., Taylor, B. S., Ellwood‐Yen, K., Gerald, W. L., Sander, C., & Sawyers, C. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017449 · Cited by 89 · see citing works

Rheb/mTORC1 Signaling Promotes Kidney Fibroblast Activation and Fibrosis

Jiang, L., Xu, L., Mao, J., Li, J., Fang, L., Zhou, Y., Liu, W., He, W., Zhao, A. Z., Yang, J., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012050476 · Cited by 89 · see citing works

The Catalytic Subunit of Phosphoinositide 3-Kinase: Requirements for Oncogenicity

Aoki, M., Schetter, C., Himly, M., Batista, O., Chang, H. W., & Vogt, P. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6267 · Cited by 88 · see citing works

Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110α and are disrupted in oncogenic p85 mutants

Wu, H., Shekar, S. C., Flinn, R. J., El‐Sibai, M., Jaiswal, B. S., Sen, K. I., Janakiraman, V., Seshagiri, S., Gerfen, G. J., Girvin, M. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902369106 · Cited by 85 · see citing works

PIK3CA and APC mutations are synergistic in the development of intestinal cancers

Deming, D. A., Leystra, A. A., Nettekoven, L. A., Sievers, C. K., Miller, D. L., Middlebrooks, M., Clipson, L. J., Albrecht, D. M., Bacher, J. W., Washington, M. K., et al. (2013) · Oncogene · doi:10.1038/onc.2013.167 · Cited by 78 · see citing works

Conditional activation of Pik3caH1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations

Yuan, W., Stawiski, E. W., Janakiraman, V., Chan, E., Durinck, S., Edgar, K. A., Kljavin, N. M., Rivers, C. S., Gnad, F., Roose‐Girma, M., et al. (2012) · Oncogene · doi:10.1038/onc.2012.53 · Cited by 77 · see citing works

Differential Requirement of mTOR in Postmitotic Tissues and Tumorigenesis

Nardella, C., Carracedo, A., Alimonti, A., Hobbs, R. M., Clohessy, J. G., Chen, Z., Egia, A., Fornari, A., Fiorentino, M., Loda, M. F., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000189 · Cited by 77 · see citing works

Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB.

Mirza, A. M., Kohn, A. D., Roth, R. A., & McMahon, M. (2000) · PubMed · Cited by 75 · see citing works

Requirement of Phosphatidylinositol(3,4,5)Trisphosphate in Phosphatidylinositol 3-Kinase-Induced Oncogenic Transformation

Denley, A., Gymnopoulos, M., Kang, S., Mitchell, C. A., & Vogt, P. K. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0068 · Cited by 74 · see citing works

PI3K isoform dependence of PTEN-deficient tumors can be altered by the genetic context

Schmit, F., Utermark, T., Zhang, S., Wang, Q., Von, T., Roberts, T. M., & Zhao, J. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323004111 · Cited by 72 · see citing works

New Inhibitors of the PI3K-Akt-mTOR Pathway: Insights into mTOR Signaling from a New Generation of Tor Kinase Domain Inhibitors (TORKinibs)

Feldman, M. E., & Shokat, K. M. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_64 · Cited by 70 · see citing works

Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma

Durban, V. M., Deuker, M. M., Bosenberg, M., Phillips, W. A., & McMahon, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69619 · Cited by 70 · see citing works

INPP4B is an oncogenic regulator in human colon cancer

Guo, S. T., Chi, M., Yang, R.-H., Guo, X., Zan, L., Wang, C.-Y., Xi, Y.-F., Jin, L., Croft, A., Tseng, H.-Y., et al. (2015) · Oncogene · doi:10.1038/onc.2015.361 · Cited by 68 · see citing works

Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma

WU, R. T., Hu, T. C., Rehemtulla, A., Fearon, E. R., & Cho, K. R. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1388 · Cited by 67 · see citing works

Physiological Levels of Pik3caH1047R Mutation in the Mouse Mammary Gland Results in Ductal Hyperplasia and Formation of ERα-Positive Tumors

Tikoo, A., Roh, V., Montgomery, K. G., Ivetac, I., Waring, P., Pelzer, R., Hare, L., Shackleton, M. J., Humbert, P. O., & Phillips, W. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036924 · Cited by 64 · see citing works

Constitutively active Rheb induces oncogenic transformation

Jiang, H., & Vogt, P. K. (2008) · Oncogene · doi:10.1038/onc.2008.180 · Cited by 63 · see citing works

Regulation of Pancreas Plasticity and Malignant Transformation by Akt Signaling

Elghazi, L., Weiss, A., Barker, D. J., Callaghan, J., Staloch, L. J., Sandgren, E. P., GANNON, M. A., Adsay, V. N., & Bernal‐Mizrachi, E. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.11.043 · Cited by 63 · see citing works

PI3′-Kinase Inhibition Forestalls the Onset of MEK1/2 Inhibitor Resistance in <i>BRAF</i> -Mutated Melanoma

Deuker, M. M., Marsh Durban, V., Phillips, W. A., & McMahon, M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0856 · Cited by 60 · see citing works

Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail

Cai, W., Ye, Q., & She, Q. (2014) · Oncotarget · doi:10.18632/oncotarget.2109 · Cited by 58 · see citing works

Mice Expressing Activated PI3K Rapidly Develop Advanced Colon Cancer

Leystra, A. A., Deming, D. A., Zahm, C. D., Farhoud, M., Olson, T. J. P., Hadac, J. N., Nettekoven, L. A., Albrecht, D. M., Clipson, L. J., Sullivan, R., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4097 · Cited by 57 · see citing works

Arid1a inactivation in an Apc‐ and Pten‐defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival

Zhai, Y., Kuick, R. D., Tipton, C. B., WU, R. T., Sessine, M. S., Wang, Z., Baker, S. J., Fearon, E. R., & Cho, K. R. (2015) · The Journal of Pathology · doi:10.1002/path.4599 · Cited by 56 · see citing works

Type I to Type II Ovarian Carcinoma Progression

WU, R. T., Baker, S. J., Hu, T. C., Norman, K. M., Fearon, E. R., & Cho, K. R. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.12.031 · Cited by 56 · see citing works

Akt Activation Synergizes with Trp53 Loss in Oral Epithelium to Produce a Novel Mouse Model for Head and Neck Squamous Cell Carcinoma

Moral, M., Segrelles, C., Lara, M. F., Martínez‐Cruz, A. B., Lorz, C., Santos, M., García‐Escudero, R., Lu, J., Kiguchi, K., Buitrago, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3240 · Cited by 55 · see citing works

Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy

Tewari, D., Patni, P., Bishayee, A., Sah, A. N., & Bishayee, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.008 · Cited by 655 · see citing works

Signaling pathways in obesity: mechanisms and therapeutic interventions

Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 456 · see citing works

Pharmacological properties and derivatives of shikonin—A review in recent years

Guo, C., He, J., Song, X., Tan, L., Wang, M., Jiang, P., Li, Y., Cao, Z., & Peng, C. Y. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104463 · Cited by 379 · see citing works

Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210

Yang, Z., Zhao, N., Cui, J. R., Wu, H., Xiong, J., & Peng, T. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00476-6 · Cited by 193 · see citing works

Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer

Morgos, D.-T., Ștefani, C., Miricescu, D., Greabu, M., Stanciu, S., Nica, S., Stănescu-Spînu, I.-I., Bălan, D. G., Balcangiu‐Stroescu, A.-E., Coculescu, E. C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031848 · Cited by 183 · see citing works

METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway

Bi, X., Lv, X., Liu, D. J., Guo, H., Yao, G., Wang, L., Liang, X., & Yang, Y. (2020) · Cancer Gene Therapy · doi:10.1038/s41417-020-00222-3 · Cited by 176 · see citing works

Long non-coding RNAs in Oral squamous cell carcinoma: biologic function, mechanisms and clinical implications

Zhang, L., Meng, X. L., Zhu, X., Yang, D., Chen, R., Jiang, Y., & Xu, T. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1021-3 · Cited by 170 · see citing works

Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway

Liang, J., Li, H., Han, J., Jiang, J. F., Wang, J., Li, Y., Feng, Z., Zhao, R., Sun, Z., Lv, B., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02858-3 · Cited by 170 · see citing works

TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer

Chi, M., Liu, J., Mei, C., Shi, Y., Liu, N., Jiang, X., Liu, C., Xue, N., Hong, H., Xie, J., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02377-3 · Cited by 167 · see citing works

Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis

Yu, Y., Peng, X.-D., Qian, X., Zhang, K., Huang, X., Chen, Y., Li, Y., Feng, G., Zhang, H., Xu, X., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00790-2 · Cited by 144 · see citing works

circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637

Zhang, Y., Li, C., Liu, X., Wang, Y., Zhao, R., Yang, Y., Zheng, X. M., Zhang, Y., & Zhang, X. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.051 · Cited by 133 · see citing works

PRMT 9 promotes hepatocellular carcinoma invasion and metastasis via activating PI 3K/Akt/ GSK ‐3β/Snail signaling

Jiang, H., Zhou, Z., Jin, S., Xu, K., Zhang, H., Xu, J., Sun, Q., Wang, J., & Xu, J. (2018) · Cancer Science · doi:10.1111/cas.13598 · Cited by 126 · see citing works

TRPM2 channel–mediated regulation of autophagy maintains mitochondrial function and promotes gastric cancer cell survival via the JNK-signaling pathway

Almasi, S., Kennedy, B. E., Elaghil, M., Sterea, A. M., Gujar, S. A., Partida‐Sánchez, S., & Hiani, Y. E. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.817635 · Cited by 126 · see citing works

MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS/AKT/mTOR signaling pathway

Zhao, S., Lu, C., Shi, Y., Li, J., Yun, Q., & Yang, H. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03336-6 · Cited by 120 · see citing works

Hypoxia Signaling in Cancer: From Basics to Clinical Practice

Sebestyén, A., Kopper, L., Dankó, T., & Tímár, J. (2021) · Pathology and Oncology Research · doi:10.3389/pore.2021.1609802 · Cited by 110 · see citing works

Pharmacological properties of indirubin and its derivatives

Lin, Y., Li, X., Huang, W., Rao, X., & Lai, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113112 · Cited by 109 · see citing works

Astaxanthin targets PI3K/Akt signaling pathway toward potential therapeutic applications

Zarneshan, S. N., Fakhri, S., Farzaei, M. H., Khan, H. Z., & Saso, L. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111714 · Cited by 106 · see citing works

Molecular biology of the cell

Si, D., Ageeva, E. S., & Żukow, W. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.08.074 · Cited by 105 · see citing works

Periostin: an emerging activator of multiple signaling pathways

Wang, Z., An, J., Zhu, D., Chen, H., Lin, A., Kang, J., Liu, W., & Kang, X. (2022) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-022-00674-2 · Cited by 101 · see citing works

PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis

Bădoiu, S. C., Greabu, M., Miricescu, D., Stănescu-Spînu, I.-I., Ilinca, R., Bălan, D. G., Balcangiu‐Stroescu, A.-E., Mihai, D. A., Văcăroiu, I. A., Ștefani, C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098391 · Cited by 99 · see citing works

Paeonol induces cytoprotective autophagy via blocking the Akt/mTOR pathway in ovarian cancer cells

Gao, L., Wang, Z., Lu, D., Huang, J., Liu, J., & Li, H. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1849-x · Cited by 93 · see citing works

Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE−/− mice

Wang, Z., Guo, J., Han, X., Xue, M., Wang, W., Mi, L., Sheng, Y., Ma, C., Wu, J., & Wu, X. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0332-9 · Cited by 91 · see citing works

Curcumin Represses Colorectal Cancer Cell Proliferation by Triggering Ferroptosis via PI3K/Akt/mTOR Signaling

Chen, M., Tan, A.-H., & Li, J. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2139398 · Cited by 88 · see citing works

Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas

Khan, T., Relitti, N., Brindisi, M., Magnano, S., Zisterer, D. M., Gemma, S., Butini, S., & Campiani, G. (2019) · Medicinal Research Reviews · doi:10.1002/med.21646 · Cited by 78 · see citing works

The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression

Wang, Z., Wang, X., Zou, H., Dai, Z., Feng, S., Zhang, M., Xiao, G., Liu, Z., & Cheng, Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01757 · Cited by 73 · see citing works

Deciphering the pharmacological mechanisms of Scutellaria baicalensis Georgi on oral leukoplakia by combining network pharmacology, molecular docking and experimental evaluations

Hou, F., Yu, Z., Cheng, Y.-H., Liu, Y., Liang, S., & Zhang, F. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154195 · Cited by 70 · see citing works

Circular RNAs and their roles in head and neck cancers

Guo, Y., Yang, J., Huang, Q., Hsueh, C., Zheng, J., Wu, C., Chen, H., & Zhou, L. F. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1003-5 · Cited by 69 · see citing works

Cellular Signaling Pathways in Medium and Large Vessel Vasculitis

Watanabe, R., Berry, G. J., Liang, D. H., Goronzy, J. J., & Weyand, C. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587089 · Cited by 65 · see citing works

The effects of mutant Ras proteins on the cell signalome

Takács, T., Kudlik, G., Kurilla, A., Szeder, B., Buday, L., & Vas, V. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09912-8 · Cited by 62 · see citing works

Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies

Qiao, L., Chen, Y., Liang, N., Xie, J. W., Deng, G., Chen, F., Wang, X., Liu, F., Li, Y., & Zhang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.775238 · Cited by 58 · see citing works

Immunometabolism in cancer: basic mechanisms and new targeting strategy

Su, R., Shao, Y., Huang, M., Liu, D., Yu, H., & Qiu, Y. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02006-2 · Cited by 60 · see citing works

Unraveling molecular networks in thymic epithelial tumors: deciphering the unique signatures

Zhang, X., Zhang, P., Cong, A., Feng, Y., Chi, H., Xia, Z., & Tang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1264325 · Cited by 54 · see citing works

Sevoflurane post-conditioning alleviates neonatal rat hypoxic-ischemic cerebral injury via Ezh2-regulated autophagy

Xue, H., Xu, Y., Wang, S., Wu, Z., Li, X.-Y., Zhang, Y., Niu, J., Gao, Q., & Zhao, P. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s197325 · Cited by 53 · see citing works

Role of the RNA-binding protein La in cancer pathobiology

Sommer, G., & Heise, T. (2020) · RNA Biology · doi:10.1080/15476286.2020.1792677 · Cited by 53 · see citing works

Autophagy Takes Center Stage as a Possible Cancer Hallmark

Alvarez-Meythaler, J. G., Garcia‐Mayea, Y., Mir, C., Kondoh, H., & LLeonart, M. E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.586069 · Cited by 53 · see citing works

Isoliquiritigenin inhibits TGF-β1-induced fibrogenesis through activating autophagy via PI3K/AKT/mTOR pathway in MRC-5 cells

He, J., Peng, H., Wang, M., Liu, Y., Guo, X., Wang, B., Dai, L., Cheng, X., Meng, Z., Yuan, L., et al. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa067 · Cited by 53 · see citing works

MALAT-1 Is a Key Regulator of Epithelial–Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis

Hussein, M. A., Valinezhad, K., Adel, E., & Munirathinam, G. (2024) · Cancers · doi:10.3390/cancers16010234 · Cited by 49 · see citing works

Trigonelline protects hippocampal neurons from oxygen-glucose deprivation-induced injury through activating the PI3K/Akt pathway

Qiu, Z., Wang, K., Jiang, C. Q., Su, Y., Fan, X., Li, J., Xue, S., & Li, Y. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.108946 · Cited by 48 · see citing works

Ginsenoside Rh1 Induces MCF-7 Cell Apoptosis and Autophagic Cell Death through ROS-Mediated Akt Signaling

Huynh, D. T. N., Jin, Y., Myung, C., & Heo, K. (2021) · Cancers · doi:10.3390/cancers13081892 · Cited by 48 · see citing works

METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma

Zhang, L., Luo, X., & Qiao, S. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01757-y · Cited by 48 · see citing works

Engineering the cellular mechanical microenvironment – from bulk mechanics to the nanoscale

Matellan, C., & Hernández, A. E. D. R. (2019) · Journal of Cell Science · doi:10.1242/jcs.229013 · Cited by 46 · see citing works

ClpP regulates breast cancer cell proliferation, invasion and apoptosis by modulating the Src/PI3K/Akt signaling pathway

Luo, J., Zeng, B., Tao, C., Lu, M., & Ren, G. (2020) · PeerJ · doi:10.7717/peerj.8754 · Cited by 44 · see citing works

Overexpression of the clock gene Per2 suppresses oral squamous cell carcinoma progression by activating autophagy via the PI3K/AKT/mTOR pathway

Liu, H., Gong, X., & Yang, K. (2020) · Journal of Cancer · doi:10.7150/jca.42771 · Cited by 45 · see citing works

Characteristics of the PI3K/AKT and MAPK/ERK pathways involved in the maintenance of self-renewal in lung cancer stem-like cells

Li, J., Wang, J., Xie, D., Qin, P., Wan, X., Xing, H., & Ye, T. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.57871 · Cited by 43 · see citing works

Hydrogen sulfide ameliorates rat myocardial fibrosis induced by thyroxine through PI3K/AKT signaling pathway

Liu, M., Li, Z., Liang, B., Li, L., Liu, S., Tan, W., Long, J., Tang, F., Chu, C., & Yang, J. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0445 · Cited by 42 · see citing works

CXCL8 and the peritoneal metastasis of ovarian and gastric cancer

Fu, X., Wang, Q., Du, H., & Hao, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1159061 · Cited by 41 · see citing works

Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer

Wu, N., Li, J., Luo, H., Wang, D., & Bai, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111227 · Cited by 41 · see citing works

Atmospheric fine particulate matter exposure exacerbates atherosclerosis in apolipoprotein E knockout mice by inhibiting autophagy in macrophages via the PI3K/Akt/mTOR signaling pathway

Wan, Q., Yang, M., Liu, Z., & Wu, J. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111440 · Cited by 40 · see citing works

Exosomal ANXA2 derived from ovarian cancer cells regulates epithelial‐mesenchymal plasticity of human peritoneal mesothelial cells

Gao, L., Nie, X., Gou, R., Hu, Y., Dong, H., Li, X., & Lin, B. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16983 · Cited by 40 · see citing works

Fusobacterium nucleatum promotes the early occurrence of esophageal cancer through upregulation of IL ‐32/ PRTN3 expression

Lei, J., Xu, F., Deng, C., Nie, X., Zhong, L., Wu, Z., Li, J., Wu, X., He, S., & Chen, Y. (2023) · Cancer Science · doi:10.1111/cas.15787 · Cited by 38 · see citing works

PI3K/AKT/p53 pathway inhibits infectious spleen and kidney necrosis virus infection by regulating autophagy and immune responses

Zhang, X., Ming, Y., Fu, X., Niu, Y., Lin, Q., Liang, H., Luo, X., Liu, L., & Li, N. (2021) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2021.12.046 · Cited by 37 · see citing works

Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy

Su, X., Li, J., Xu, X., Ye, Y., Wang, C., Pang, G., Liu, W., Liu, A., Zhao, C., & Hao, X. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05552-6 · Cited by 41 · see citing works

Molecular events in the pathogenesis of vulvar squamous cell carcinoma

Xing, D., & Fadare, O. (2020) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2020.09.010 · Cited by 38 · see citing works

Inhibition of PHLPP1 ameliorates cardiac dysfunction via activation of the PI3K/Akt/mTOR signalling pathway in diabetic cardiomyopathy

Zhang, M., Wang, X., Liu, M., Liu, D., Pan, J., Tian, J., Jin, T., Xu, Y., & An, F. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15123 · Cited by 37 · see citing works

Ligustrazine induces viability, suppresses apoptosis and autophagy of retinal ganglion cells with ischemia/reperfusion injury through the PI3K/Akt/mTOR signaling pathway

Du, H., Wang, R., Li, J., Luo, H., Xie, X.-Y., Yan, R., Jian, Y.-L., & Cai, J.-Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.1880060 · Cited by 36 · see citing works

Reprogramming of central carbon metabolism in hepatocellular carcinoma

Xia, H., Huang, Z., Xu, Y., Yam, J. W. P., & Cui, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113485 · Cited by 38 · see citing works

New light on treatment of cervical cancer: Chinese medicine monomers can be effective for cervical cancer by inhibiting the PI3K/Akt signaling pathway

Liu, F., Xu, J., Yang, R., Liu, S., Hu, S., Yan, M.-Y., & Han, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114084 · Cited by 35 · see citing works

Lipid Regulatory Proteins as Potential Therapeutic Targets for Ovarian Cancer in Obese Women

Yang, J., & Stack, M. S. (2020) · Cancers · doi:10.3390/cancers12113469 · Cited by 35 · see citing works

2-Undecanone Protects against Fine Particle-Induced Kidney Inflammation via Inducing Mitophagy

Wu, X., Li, J., Wang, S., Jiang, L., Sun, X., Liu, X., Yao, X., Zhang, C., Wang, N., & Yang, G. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c01305 · Cited by 35 · see citing works

Posttranslational control of lipogenesis in the tumor microenvironment

Zhu, Y., Lin, X., Zhou, X., Prochownik, E. V., Wang, X., & Li, Y. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01340-1 · Cited by 36 · see citing works

E-cadherin on epithelial–mesenchymal transition in thyroid cancer

Zhu, X., Wang, X., Gong, Y., & Deng, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02344-6 · Cited by 35 · see citing works

The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia

Gallez, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.853568 · Cited by 34 · see citing works

miR-496 suppress tumorigenesis via targeting BDNF-mediated PI3K/Akt signaling pathway in non-small cell lung cancer

Ma, R., Zhu, P., Liu, S., Gao, B., & Wang, W. T. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.046 · Cited by 33 · see citing works

PI3K/Akt/mTOR Pathways Inhibitors with Potential Prospects in Non-Small-Cell Lung Cancer

Alharbi, K. S., Shaikh, M. A. J., Almalki, W. H., Kazmi, I. A., Al-Abbasi, F. A., Alzarea, S. I., Imam, S. S., Alshehri, S., Ghoneim, M. M., Singh, S. K., et al. (2022) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.2022042281 · Cited by 32 · see citing works

Downregulation of miR ‐100‐5p in cancer‐associated fibroblast‐derived exosomes facilitates lymphangiogenesis in esophageal squamous cell carcinoma

Chen, C., Yang, C., Tian, X., Liang, Y., Wang, S., Wang, X., Shou, Y., Li, H., Xiao, Q., Shu, J., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.6078 · Cited by 32 · see citing works

Combination effect of curcumin with docetaxel on the PI3K/AKT/mTOR pathway to induce autophagy and apoptosis in esophageal squamous cell carcinoma.

Deng, L., Wu, X., Zhu, X., Yu, Z., Liu, Z., Wang, J., & Zheng, Y. (2021) · Europe PMC (PubMed Central) · Cited by 31 · see citing works

LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway

Xu, R., Zhang, Y., Li, A., Ma, Y., Cai, W., Li, S., Xie, Y., Zhou, S., Cao, W., & Tang, X. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12147 · Cited by 31 · see citing works

Kinesin family member 18B regulates the proliferation and invasion of human prostate cancer cells

Wu, Y., Ke, Z., Zheng, W., Chen, Y., Zhu, J., Lin, F., Li, X., Chen, S., Cai, H., Zheng, Q., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03582-2 · Cited by 30 · see citing works

Autophagy controls programmed death‑ligand 1 expression on cancer cells (Review)

Gao, L., & Chen, Y. (2021) · Biomedical Reports · doi:10.3892/br.2021.1460 · Cited by 30 · see citing works

Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer

Deng, L., Wang, D., Chen, S., Hu, W., & Zhang, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653782 · Cited by 30 · see citing works

mTOR signaling: A pivotal player in Treg cell dysfunction in systemic lupus erythematosus

Zhao, X., Wang, S., Wang, S., Xie, J., & Cui, D. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109153 · Cited by 30 · see citing works

Exploration in the Mechanism of Kaempferol for the Treatment of Gastric Cancer Based on Network Pharmacology

Yang, L., Li, H., Yang, M., Zhang, W., Li, M., Xu, Y., Li, J., Kang, J., Zhang, J.-C., & Guo, S. (2020) · BioMed Research International · doi:10.1155/2020/5891016 · Cited by 30 · see citing works

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy

Godiyal, Y., Maheshwari, D., Taniguchi, H., Zinzuwadia, S. S., Díaz, Y. M., Tewari, D., & Bishayee, A. (2024) · Military Medical Research · doi:10.1186/s40779-024-00586-9 · Cited by 31 · see citing works

Let-7a inhibits migration, invasion and tumor growth by targeting AKT2 in papillary thyroid carcinoma

Zhou, B., Shan, H., Su, Y., Xia, K., Zou, R., & Shao, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.19261 · Cited by 29 · see citing works

MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway

Qiu, C., Su, W., Shen, N., Qi, X., Wu, X., Wang, K., Lin, L., Guo, Z., Tao, H., Wang, G., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07687-3 · Cited by 29 · see citing works

Autophagy in vascular dementia and natural products with autophagy regulating activity

Wang, W., Qiao, O., Ji, H., Zhang, X., Han, X., Zhang, Y., Wang, J., Li, X., & Gao, W. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105756 · Cited by 30 · see citing works

MiR-1246 regulates the PI3K/AKT signaling pathway by targeting PIK3AP1 and inhibits thyroid cancer cell proliferation and tumor growth

Li, J., Zhang, Z., Hu, J.-T., Wan, X., Huang, W., Zhang, H., & Jiang, N. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04290-3 · Cited by 29 · see citing works

Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers

Shan, K. S., Bonano-Rios, A. M., Theik, N. W. Y., Hussein, A. M., & Blaya, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041973 · Cited by 30 · see citing works

Regulatory Mechanisms and Clinical Applications of the Long Non-coding RNA PVT1 in Cancer Treatment

Li, M., Tang, X., Fu, Y., Wang, T., & Zhu, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00787 · Cited by 27 · see citing works

Curcumin enhances the membrane trafficking of the sodium iodide symporter and augments radioiodine uptake in dedifferentiated thyroid cancer cells via suppression of the PI3K-AKT signaling pathway

Zhang, L., Xu, S., Cheng, X. F., Wu, J., Wang, X., Wu, L., Yu, H., & Bao, J. (2021) · Food & Function · doi:10.1039/d1fo01073e · Cited by 27 · see citing works

Endothelial cell-specific molecule 1 drives cervical cancer progression

Lu, J., Liu, Q., Zhu, L., Liu, Y., Zhu, X., Peng, S.-Q., Chen, M., & Li, P. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05501-5 · Cited by 27 · see citing works

The Interplay of Autophagy and Oxidative Stress in the Kidney: What Do We Know?

Guo, H., & Bechtel‐Walz, W. (2023) · The Nephron journals/Nephron journals · doi:10.1159/000531290 · Cited by 27 · see citing works

The remodeling roles of lipid metabolism in colorectal cancer cells and immune microenvironment

Zhong, J., GUO, J., ZHANG, X., FENG, S., Di, W., WANG, Y., & ZHU, H. (2022) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2022.027900 · Cited by 26 · see citing works

Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142

Zhang, L., Zhao, G., Ji, S., Yuan, Q., & Zhou, H. (2020) · Medical Science Monitor · doi:10.12659/msm.921594 · Cited by 27 · see citing works

20(S)-ginsenoside Rh2 induces caspase-dependent promyelocytic leukemia-retinoic acid receptor A degradation in NB4 cells via Akt/Bax/caspase9 and TNF-α/caspase8 signaling cascades

Zhu, S., Liu, X., Xue, M., Li, Y., Cai, D., Wang, S., & Zhang, L. (2020) · Journal of Ginseng Research · doi:10.1016/j.jgr.2020.05.001 · Cited by 26 · see citing works

MiR-491-5p, as a Tumor Suppressor, Prevents Migration and Invasion of Breast Cancer by Targeting ZNF-703 to Regulate AKT/mTOR Pathway

Guo, J., Luo, C., Yang, Y., Dong, J., Guo, Z., Yang, J., Lian, H., Ye, C., & Liu, M. (2021) · Cancer Management and Research · doi:10.2147/cmar.s279747 · Cited by 26 · see citing works

QiShenYiQi pill activates autophagy to attenuate reactive myocardial fibrosis via the PI3K/AKT/mTOR pathway

Lv, S., Yuan, P., Lu, C., Dong, J., Li, M., Qu, F., Zhu, Y., & Zhang, J. (2021) · Aging · doi:10.18632/aging.202482 · Cited by 26 · see citing works

MicroRNA-34a: A Novel Therapeutic Target in Fibrosis

Zhao, M., Qi, Q., Liu, S., Huang, R. S., Shen, J., Zhu, Y., Chai, J., Zheng, H., Wu, H., & Liu, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.895242 · Cited by 26 · see citing works

Capsaicin alleviates doxorubicin-induced acute myocardial injury by regulating iron homeostasis and PI3K-Akt signaling pathway

Wang, L., Liu, Y., Li, S., Zha, Z., Chen, Y., Wang, Q., Zhou, S., Huang, X., & Xu, M. (2023) · Aging · doi:10.18632/aging.205138 · Cited by 27 · see citing works

Overexpressing natural killer group 2 member A drives natural killer cell exhaustion in relapsed acute myeloid leukemia

Xie, J., Liu, X., Zhou, T., Liu, L., Hou, R., Yu, X., Fan, Z., Shang, Q., Chang, Y., Zhao, X.-S., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02228-5 · Cited by 25 · see citing works

The silencing of FNDC1 inhibits the tumorigenesis of breast cancer cells via modulation of the PI3K/Akt signaling pathway

Chen, Y., Shanshan, G., Zhifei, B., Chen, S., & Yin, H. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12118 · Cited by 25 · see citing works

Differential Expression Profiles of lncRNA Following LPS-Induced Inflammation in Bovine Mammary Epithelial Cells

Wang, J., Hu, Q., Yang, J., Luoreng, Z., Wang, X., Ma, Y., & Wei, D. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.758488 · Cited by 25 · see citing works

Insulin-Like Growth Factor-1 Promotes Human Uterine Leiomyoma Cell Proliferation via PI3K/AKT/mTOR Pathway

Wang, C., Sun, Y., Cong, S., & Zhang, F. (2022) · Cells Tissues Organs · doi:10.1159/000525186 · Cited by 25 · see citing works

Taxifolin Targets PI3K and mTOR and Inhibits Glioblastoma Multiforme

Yao, W., Gong, H., Mei, H., Shi, L., Yu, J., & Hu, Y. (2021) · Journal of Oncology · doi:10.1155/2021/5560915 · Cited by 24 · see citing works

Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis

Zhang, R., Lian, Y., Xie, K., Cai, Y., Pan, Y., & Zhu, Y. (2021) · Bioengineered · doi:10.1080/21655979.2021.1995103 · Cited by 24 · see citing works

Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance

Gao, Y., Feng, C., Ma, J., & Yan, Q. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116048 · Cited by 23 · see citing works

Isoferulic acid inhibits human leukemia cell growth through induction of G2/M‑phase arrest and inhibition of Akt/mTOR signaling

Long, Z., Feng, G., Zhao, N., Wu, L., & Zhu, H. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.10926 · Cited by 23 · see citing works

MLLT11-TRIL complex promotes the progression of endometrial cancer through PI3K/AKT/mTOR signaling pathway

Liao, J., Chen, H., Qi, M., Wang, J., & Wang, M. (2022) · Cancer Biology & Therapy · doi:10.1080/15384047.2022.2046450 · Cited by 23 · see citing works

LINC00958: A promising long non-coding RNA related to cancer

Li, H., Gao, J., Liu, L., & Zhang, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113087 · Cited by 23 · see citing works

Abstract PL02-01: Targeting the PI3K pathway in cancer

Sellers, W. R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-09-pl02-01

Role of PI3K/AKT/mTOR in Cancer Signaling

Owusu‐Brackett, N., Shariati, M., & Meric‐Bernstam, F. (2018) · Springer eBooks · doi:10.1007/978-3-319-95228-4_20 · Cited by 24 · see citing works

PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?

Peng, Y., Wang, Y., Zhou, C., Mei, W., & Zeng, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.819128 · Cited by 775 · see citing works

PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment

Jiang, M., Zhang, K., Zhang, Z., Zeng, X., Huang, Z., Qin, P., Xie, Z., Cai, X., Ashrafizadeh, M., Tian, Y., et al. (2025) · MedComm · doi:10.1002/mco2.70295 · Cited by 173 · see citing works

A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt

Aoki, M., Blazek, E., & Vogt, P. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.136 · Cited by 306 · see citing works